Search
-
Arexvy 50 59 Press Release (1)
Media
https://www.gsk.com/media/10650/arexvy-50-59-press-release.pdf
First published: 25 October 2023
-
Press Release Japan File Acceptance Arexvy 50 59
Media
https://www.gsk.com/media/10737/press-release_japan-file-acceptance-arexvy-50-59.pdf
First published: 12 December 2023
-
Merrill Lynch Conference Julian Heslp Cfo
Media
https://www.gsk.com/media/8324/merrill-lynch-conference-julian-heslp-cfo.pdf
First published: 07 June 2022
-
The decade of vaccines collaboration and the global vaccine action plan
Media
https://www.gsk.com/media/1196/gsk-gvap-long-version-vr75.pdf
First published: 01 February 2023
-
GSK Position On The Nagoya Protocol And Access And Benefit Sharing Of Genetic Resources
Media
https://www.gsk.com/media/8350/gsk-position-on-the-nagoya-protocol-and-access-and-benefit-sharing-of-genetic-resources.pdf
First published: 07 June 2022
-
GSK Position On Nagoya Protocol And Access And Benefit Sharing March 2022
Media
https://www.gsk.com/media/8839/gsk-position-on-nagoya-protocol-and-access-and-benefit-sharing-march-2022.pdf
First published: 27 June 2022
-
Press Release Japan Accepts Arexvy Regulatory Application To Prevent RSV Disease In Adults Aged 50 59
Media
https://www.gsk.com/media/10736/press-release-japan-accepts-arexvy-regulatory-application-to-prevent-rsv-disease-in-adults-aged-50-59.pdf
First published: 12 December 2023
-
Opening and plenary session
Media
https://www.gsk.com/media/10360/20230620-evnt-id23-bos0.pdf
First published: 27 June 2023
-
Gsk Rsv Transcript 27Oct20 Final
Media
https://www.gsk.com/media/8032/gsk-rsv-transcript-27oct20-final.pdf
First published: 01 June 2022
-
2016 Gsk Vaccines Meet The Management Transcript
Media
https://www.gsk.com/media/8178/2016-gsk-vaccines-meet-the-management-transcript.pdf
First published: 06 June 2022